H44.00 Unspecified purulent endophthalmitis

Name of the Condition

• Unspecified Purulent Endophthalmitis

Summary

Unspecified purulent endophthalmitis is a severe intraocular infection marked by the presence of pus within the eye, typically affecting the vitreous or aqueous humor. It is a sight-threatening condition that requires immediate medical attention to prevent permanent vision loss. The term "unspecified" indicates that the specific location or cause of the infection is not detailed in the documentation.

Causes

The condition is most commonly caused by bacterial or fungal infections, which may enter the eye through trauma, surgery, or systemic spread. Postoperative infections, particularly after cataract or retinal surgery, are a frequent cause. Less commonly, it may result from endogenous sources, such as septicemia. The unspecified nature of the code suggests the documentation does not specify the exact etiology or location.

Risk Factors

• Recent eye surgery (e.g., cataract, glaucoma, or retinal procedures).
• Penetrating eye trauma.
• Immunocompromised states (e.g., diabetes, HIV, or immunosuppressive therapy).
• Pre-existing ocular infections or inflammation.
• Use of intraocular devices or implants.

Symptoms

• Sudden, severe eye pain.
• Marked decrease in vision or vision loss.
• Redness and swelling of the eye.
• Sensitivity to light (photophobia).
• Discharge or pus visible in the eye.
• Floaters or a "cobweb" sensation in the visual field.

Diagnosis

Diagnosis is based on clinical evaluation, including a detailed eye examination and history of recent procedures or trauma. Slit-lamp examination may reveal anterior chamber inflammation, hypopyon (pus in the anterior chamber), or vitreous haze. Ultrasound or optical coherence tomography (OCT) may be used to assess the extent of infection. Cultures of intraocular fluids or samples may be obtained to identify the causative organism, though the unspecified nature of the code implies this detail is not documented.

Treatment Options

• Antibiotics or Antifungals: Intravitreal or systemic medications to target the infection.
• Surgical Intervention: Vitrectomy to remove infected vitreous and administer medications directly.
• Anti-inflammatory Agents: To reduce inflammation and prevent further damage.
• Supportive Care: Pain management and monitoring of intraocular pressure.

Prognosis and Follow-Up

Prognosis depends on the timeliness of treatment and the severity of the infection. Early intervention improves outcomes, but vision loss may still occur. Follow-up care includes regular eye examinations to monitor for recurrence or complications, such as retinal detachment or glaucoma. Long-term vision may be impaired even with treatment.

Complications

• Permanent vision loss or blindness.
• Retinal detachment.
• Glaucoma.
• Cataract formation.
• Spread of infection to other parts of the eye or body.

Lifestyle & Prevention

• Avoid eye trauma by using protective eyewear.
• Follow postoperative care instructions after eye surgery.
• Manage systemic conditions like diabetes to reduce infection risk.
• Seek prompt treatment for ocular infections or injuries.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden severe eye pain, vision loss, or signs of infection (e.g., redness, discharge). Delay in treatment can worsen outcomes.

Tips for Medical Coders

When coding H44.00, ensure the documentation supports the diagnosis of purulent endophthalmitis without specifying location or cause. If the record indicates a more detailed etiology (e.g., postoperative or traumatic) or location (e.g., anterior or posterior), a more specific code may be appropriate. Verify that the term "unspecified" aligns with the lack of additional details in the clinical notes.